← Leaderboards
Doug Christensen
University Of Nebraska Medical Center
$295,186
Attributed
$295,186
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $60.6K · FY2005–11$100K$75K$50K$25K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$295,186 · 7
By mechanism
P20$295,186 · 7
Top collaborators
No co-investigators on record.
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- Kenneth Cowan$25,385,222
- James B Turpen$19,347,748
- Maurice Godfrey$7,053,449
- Tatiana K Bronich$14,219,791
- Shelley D. Smith$12,095,613
Others in their field
Top investigators on “Resources”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$688,986,350
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Eric S Lander · Whitehead Institute For Biomedical Res$341,717,134
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$311,514,701
Research focus
ResourcesProteinsGenesFundingCellsListeria MonocytogenesUnited States National Institutes Of HealthSourceGrantInstitutionComputer Retrieval Of Information On Scientific Projects DatabaseResearch PersonnelElbowCell InjuryLearningInfectionBaseImmune SystemLifeGlucoseBacteriaAntigensFetalB-Lymphocytes
Grant awards (7)
LISTERIA MONOCYTOGENES INIA AND INIB FOR USE IN DRUG DELIVERY$46,982
P20 · FY2011 · RR · contact PI
LISTERIA MONOCYTOGENES INIA AND INIB FOR USE IN DRUG DELIVERY$46,290
P20 · FY2010 · RR · contact PI
HUMAN CELL-PATHOGEN INTERACTION$28,974
P20 · FY2009 · RR · contact PI
HUMAN CELL-PATHOGEN INTERACTION$32,316
P20 · FY2008 · RR · contact PI
HUMAN CELL-PATHOGEN INTERACTION$39,442
P20 · FY2007 · RR · contact PI
HUMAN CELL-PATHOGEN INTERACTION$40,620
P20 · FY2006 · RR · contact PI
HUMAN CELL-PATHOGEN INTERACTION$60,562
P20 · FY2005 · RR